Fastenal's stock has gained nearly 30% year-to-date, reflecting strong operational performance. However, the shares currently trade at a high forward price-to-earnings ratio of 40x, suggesting a premium valuation. The company is set to release its Q3 earnings on October 14, which investors will watch closely. Given the rich valuation, the stock is considered a 'hold' at current levels rather than a buy or sell.
Fastenal's upcoming Q3 earnings preview is offered with Pluang's Industrials sector data as of Oct 07, 2026 21:22 WIB. Of 93 priced Industrials-sector US stocks tradable on Pluang, 15 rose and 78 fell today. Notable movers include FCEL at USD 17.79 with a 1-day change of -13.85%, SMR at USD 7.51 down 6.42%, and ALLE at USD 145.69 down 6.13%.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
